| abstract |
The disclosures herein provide compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for non-invasive oral administration, invasive, intravenous, transdermal administration, or injection. Such compositions may be used to treatment of cancer and its metastasis or its associated complications. |